TY - JOUR ID - 47336 TI - COVID-19 Vaccine Global Access Is an Urgency JO - Iranian Journal of Medical Sciences JA - IJMS LA - en SN - 0253-0716 AU - Negahdaripour, Manica AD - Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Y1 - 2021 PY - 2021 VL - 46 IS - 2 SP - 79 EP - 80 KW - Covid KW - 19 DO - 10.30476/ijms.2021.47336 N2 - After almost one year of intense global struggle with SARS-CoV-2 since its first report in Dec. 2019, the introduction of several vaccines for COVID-19 prevention has revived hopes in many people around the world. Several vaccines already approved or started to use in different countries are mostly developed based on the spike antigens of SARS-CoV-2, which not only is involved in cell receptor recognition and virulence, but also is very antigenic. UR - https://ijms.sums.ac.ir/article_47336.html L1 - https://ijms.sums.ac.ir/article_47336_f27b4fa11479ec8d5590dfb8773763ab.pdf ER -